Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Companies 1/25
Result 223 decisions over 120 months
Reset filters
Minimum amount ? Share of their own holding ?
What the chief executive holds ?
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
23 Dec 2025
President & Immunovant CEO
Sold at will
200,000
$4.49M
11.0%
17 Dec 2025
Director by Deputization indirect
Sold at will
777,332
$17.94M
4.5%
17 Dec 2025
Director indirect
Sold at will
777,332
$17.94M
4.5%
17 Dec 2025
Director indirect
Sold at will
777,332
$17.94M
4.5%
17 Dec 2025
President & CIO
Sold at will
26,831
$619.53K
0.1%
16 Dec 2025
Director by Deputization indirect
Sold at will
917,282
$21.13M
5.1%
16 Dec 2025
Director indirect
Sold at will
917,282
$21.13M
5.1%
16 Dec 2025
Director indirect
Sold at will
917,282
$21.13M
5.1%
15 Dec 2025
CEO
Sold at will
1,740,000
$37.72M
9.1%
15 Dec 2025
10% owner
Sold at will
353,745
$7.80M
1.0%
12 Dec 2025
10% owner
Sold at will
1,975,858
$43.39M
5.2%
11 Dec 2025
10% owner
Sold at will
774,142
$16.75M
2.2%
9 Dec 2025
President & Immunovant CEO
Sold on a plan
200,000
$4.17M
11.8%
19 Nov 2025
Director by Deputization indirect
Sold at will
1,300,000
$26.30M
6.7%
19 Nov 2025
Director indirect
Sold at will
1,300,000
$26.30M
6.7%
19 Nov 2025
Director indirect
Sold at will
1,300,000
$26.30M
6.7%
17 Nov 2025
10% owner
Sold at will
539,650
$11.07M
1.6%
14 Nov 2025
10% owner
Sold at will
1,027,670
$20.89M
2.9%
13 Nov 2025
10% owner
Sold at will
287,283
$5.98M
0.8%
7 Nov 2025
President & Immunovant CEO
Sold on a plan
200,000
$4.04M
11.7%
17 Oct 2025
President & Immunovant CEO
Sold on a plan
118,418
$2.02M
7.3%
16 Oct 2025
President & Immunovant CEO
Sold on a plan
318,282
$5.43M
17.5%
15 Oct 2025
President & Immunovant CEO
Sold on a plan
414,683
$7.02M
21.6%
13 Oct 2025
President & Immunovant CEO
Sold on a plan
20,727
$336.81K
1.4%
9 Oct 2025
President & Immunovant CEO
Sold on a plan
104,940
$1.71M
6.5%
8 Oct 2025
President & Immunovant CEO
Sold on a plan
138,602
$2.25M
8.4%
7 Oct 2025
President & Immunovant CEO
Sold on a plan
355,161
$5.74M
19.1%
6 Oct 2025
President & Immunovant CEO
Sold on a plan
171,396
$2.80M
10.2%
23 Sep 2025
President & Immunovant CEO
Sold on a plan
611,000
$9.06M
28.9%
22 Sep 2025
President & Immunovant CEO
Sold on a plan
416,182
$6.24M
16.4%
19 Sep 2025
President & Immunovant CEO
Sold on a plan
683,818
$10.22M
25.8%
18 Sep 2025
CEO
Bought
3,315
$49.96K
0.0%
5 Sep 2025
10% owner
Sold at will
385,816
$5.00M
1.1%
4 Sep 2025
10% owner
Sold at will
194,933
$2.52M
0.5%
3 Sep 2025
10% owner
Sold at will
1,195,000
$14.94M
3.2%
20 Aug 2025
President & Immunovant CEO
Sold on a plan
100,000
$1.17M
5.7%
21 Jul 2025
President & Immunovant CEO
Sold on a plan
100,000
$1.15M
6.4%
20 Jun 2025
10% owner
Sold at will
577,007
$6.61M
1.5%
20 Jun 2025
President & COO
Sold on a plan
100,000
$1.15M
6.4%
18 Jun 2025
10% owner
Sold at will
565,266
$6.47M
1.5%
6 Jun 2025
10% owner
Sold at will
200,800
$2.25M
0.5%
4 Jun 2025
10% owner
Sold at will
547,430
$6.21M
1.4%
3 Jun 2025
President & COO
Sold at will
566,278
$6.35M
27.9%
2 Jun 2025
President & COO
Sold at will
433,722
$4.80M
25.9%
20 May 2025
President & COO
Sold on a plan
100,000
$1.10M
8.5%
7 May 2025
10% owner
Sold at will
625,000
$6.99M
1.6%
6 May 2025
10% owner
Sold at will
273,959
$3.14M
0.7%
21 Apr 2025
President & COO
Sold on a plan
100,000
$1.02M
8.2%
24 Mar 2025
President & COO
Sold on a plan
434,478
$4.70M
27.8%
20 Mar 2025
President & COO
Sold on a plan
315,522
$3.49M
24.7%
Showing 51–100 of 223. ← Newer Page 2 of 5 Older →